Sources | Names Used |
---|---|
CTRPv2 | ML334 diastereomer |
PharmacoGx | ML334 diastereomer |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | UBN1 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.09 |
mRNA | PLXNC1 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.09 |
mRNA | NFIC | CTRPv2 | pan-cancer | AAC | 0.091 | 0.09 |
mRNA | ATXN7L3 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.09 |
mRNA | SPRR2D | CTRPv2 | pan-cancer | AAC | 0.079 | 0.09 |
mRNA | BIVM-ERCC5 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.09 |
mRNA | GNB1L | CTRPv2 | pan-cancer | AAC | -0.075 | 0.09 |
mRNA | H2AFY | CTRPv2 | pan-cancer | AAC | -0.078 | 0.09 |
mRNA | ICOS | CTRPv2 | pan-cancer | AAC | 0.073 | 0.09 |
mRNA | MED8 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.09 |